Source: BUSINESS WIRE

Press Release: Gene Signal : Research and Markets: Corneal Neovascularization Therapeutics Pipeline Review 2015 - 4 Companies & 10 Drug Profiles

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/fmk9dw/corneal) has announced the addition of the "Corneal Neovascularization - Pipeline Review, H1 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Corneal Neovascularization, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule typ

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Eric Viaud's photo - Co-Founder & CEO of Gene Signal

Co-Founder & CEO

Eric Viaud

CEO Approval Rating

81/100

Read more